(data stored in ACNUC7421 zone)

HOGENOM: PSEPF_1_PE1012

ID   PSEPF_1_PE1012                       STANDARD;      PRT;   393 AA.
AC   PSEPF_1_PE1012; Q3KHJ9;
DT   00-JAN-0000 (Rel. 1, Created)
DT   00-JAN-0000 (Rel. 2, Last sequence update)
DT   00-JAN-0000 (Rel. 3, Last annotation update)
DE   RecName: Full=Phosphoribosylglycinamide formyltransferase 2; Short=GART
DE   2; EC=2.1.2 -;AltName: Full=5'-phosphoribosylglycinamide transformylase
DE   2;AltName: Full=Formate-dependent GAR transformylase;AltName: Full=GAR
DE   transformylase 2; (PSEPF_1.PE1012).
GN   Name=purT; OrderedLocusNames=Pfl01_1014;
OS   PSEUDOMONAS FLUORESCENS PF0-1.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=205922;
RN   [0]
RP   -.;
RG   -.;
RL   -.;
CC   -!- SEQ. DATA ORIGIN: Translated from the HOGENOM CDS PSEPF_1.PE1012.
CC       Pseudomonas fluorescens Pf0-1, complete genome.
CC       sequence.
CC   -!- ANNOTATIONS ORIGIN:PURT_PSEPF
CC   -!- FUNCTION: Catalyzes two reactions: the first one is the production
CC       of beta-formyl glycinamide ribonucleotide (GAR) from formate, ATP
CC       and beta GAR; the second, a side reaction, is the production of
CC       acetyl phosphate and ADP from acetate and ATP (By similarity).
CC   -!- CATALYTIC ACTIVITY: Formate + ATP + 5'-phospho-ribosylglycinamide
CC       = 5'-phosphoribosyl-N-formylglycinamide + ADP + diphosphate.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway;
CC       N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide from N(1)-(5-
CC       phospho-D-ribosyl)glycinamide (formate route): step 1/1.
CC   -!- SUBUNIT: Homodimer (By similarity).
CC   -!- SIMILARITY: Belongs to the purK/purT family.
CC   -!- SIMILARITY: Contains 1 ATP-grasp domain.
CC   -!- GENE_FAMILY: HOG000072820 [ FAMILY / ALN / TREE ]
DR   UniProtKB/Swiss-Prot; Q3KHJ9; -.
DR   EMBL; CP000094; ABA72757.1; -; Genomic_DNA.
DR   RefSeq; YP_346746.1; NC_007492.2.
DR   ProteinModelPortal; Q3KHJ9; -.
DR   SMR; Q3KHJ9; 2-392.
DR   STRING; Q3KHJ9; -.
DR   GeneID; 3716016; -.
DR   GenomeReviews; CP000094_GR; Pfl01_1014.
DR   KEGG; pfo:Pfl01_1014; -.
DR   eggNOG; COG0027; -.
DR   OMA; PDYIVPE; -.
DR   ProtClustDB; PRK09288; -.
DR   BioCyc; PFLU205922:PFL_1014-MON; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016742; F:hydroxymethyl-, formyl- and related transferase activity; IEA:InterPro.
DR   GO; GO:0016874; F:ligase activity; IEA:InterPro.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0009152; P:purine ribonucleotide biosynthetic process; IEA:InterPro.
DR   HAMAP; MF_01643; PurT; 1; -.
DR   InterPro; IPR011761; ATP-grasp.
DR   InterPro; IPR003135; ATP-grasp_carboxylate-amine.
DR   InterPro; IPR013815; ATP_grasp_subdomain_1.
DR   InterPro; IPR013816; ATP_grasp_subdomain_2.
DR   InterPro; IPR013817; Pre-ATP_grasp.
DR   InterPro; IPR016185; PreATP-grasp-like.
DR   InterPro; IPR005862; PurT.
DR   Gene3D; G3DSA:3.30.1490.20; ATP_grasp_subdomain_1; 1.
DR   Gene3D; G3DSA:3.30.470.20; ATP_grasp_subdomain_2; 1.
DR   Gene3D; G3DSA:3.40.50.20; Pre-ATP_grasp; 1.
DR   PANTHER; PTHR23047:SF2; PurT; 1.
DR   Pfam; PF02222; ATP-grasp; 1.
DR   SUPFAM; SSF52440; PreATP-grasp-like; 1.
DR   TIGRFAMs; TIGR01142; PurT; 1.
DR   PROSITE; PS50975; ATP_GRASP; 1.
DR   HOGENOMDNA; PSEPF_1.PE1012; -.
KW   phosphoribosylglycinamide formyltransferase 2;
KW   ATP-binding; Complete proteome; Magnesium; Metal-binding;
KW   Nucleotide-binding; Purine biosynthesis; Transferase.
SQ   SEQUENCE   393 AA;  UNKNOWN MW;  UNKNOWN CRC64;
     MTRIGTPLSP TATRVLLCGC GELGKEVVIE LQRLGVEVIA VDRYANAPAM QVAHRSHVIN
     MLDGAALRAV IEAEKPHFIV PEIEAIATAT LVALEAEGFT VIPTARAAQL TMNREGIRRL
     AAEELDLPTS PYHFADTFED YSKAVQDLGF PCVVKPVMSS SGKGQSLLRS ADDVQKAWDY
     AQEGGRAGKG RVIIEGFIDF DYEITLLTVR HVGGTTFCAP VGHRQEKGDY QESWQPQAMS
     PVALAESERV AKAVTEALGG RGLFGVELFI KGDQVWFSEV SPRPHDTGLV TLISQDLSQF
     ALHARAILGL PVPLIRQFGP SASAVILVEG QSTQTAFANL GAALSEPDTA LRLFGKPEVN
     GQRRMGVALA RDESIEAARA KATRASQAVV VEL
//

If you have problems or comments...

PBIL Back to PBIL home page